479 related articles for article (PubMed ID: 26396175)
1. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
Concepcion AR; Salas JT; Sáez E; Sarvide S; Ferrer A; Portu A; Uriarte I; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
Oncotarget; 2015 Oct; 6(30):28588-606. PubMed ID: 26396175
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of the
Arenas F; Hervías I; Sáez E; Melero S; Prieto J; Parés A; Medina JF
JHEP Rep; 2019 Sep; 1(3):145-153. PubMed ID: 32039364
[TBL] [Abstract][Full Text] [Related]
3. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.
Salas JT; Banales JM; Sarvide S; Recalde S; Ferrer A; Uriarte I; Oude Elferink RP; Prieto J; Medina JF
Gastroenterology; 2008 May; 134(5):1482-93. PubMed ID: 18471521
[TBL] [Abstract][Full Text] [Related]
4. Anion exchanger 2 is critical for CD8(+) T cells to maintain pHi homeostasis and modulate immune responses.
Concepcion AR; Salas JT; Sarvide S; Sáez E; Ferrer A; López M; Portu A; Banales JM; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
Eur J Immunol; 2014 May; 44(5):1341-51. PubMed ID: 24515893
[TBL] [Abstract][Full Text] [Related]
5. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.
Pauken KE; Nelson CE; Martinov T; Spanier JA; Heffernan JR; Sahli NL; Quarnstrom CF; Osum KC; Schenkel JM; Jenkins MK; Blazar BR; Vezys V; Fife BT
J Immunol; 2015 Apr; 194(8):3551-3555. PubMed ID: 25769925
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.
Banales JM; Sáez E; Uriz M; Sarvide S; Urribarri AD; Splinter P; Tietz Bogert PS; Bujanda L; Prieto J; Medina JF; LaRusso NF
Hepatology; 2012 Aug; 56(2):687-97. PubMed ID: 22383162
[TBL] [Abstract][Full Text] [Related]
9. Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis.
Medina JF
Dig Dis; 2011; 29(1):103-12. PubMed ID: 21691115
[TBL] [Abstract][Full Text] [Related]
10. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.
Stein S; Henze L; Poch T; Carambia A; Krech T; Preti M; Schuran FA; Reich M; Keitel V; Fiorotto R; Strazzabosco M; Fischer L; Li J; Müller LM; Wagner J; Gagliani N; Herkel J; Schwinge D; Schramm C
J Hepatol; 2021 Apr; 74(4):919-930. PubMed ID: 33197512
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis.
Hisamoto S; Shimoda S; Harada K; Iwasaka S; Onohara S; Chong Y; Nakamura M; Bekki Y; Yoshizumi T; Ikegami T; Maehara Y; He XS; Gershwin ME; Akashi K
J Autoimmun; 2016 Dec; 75():150-160. PubMed ID: 27592379
[TBL] [Abstract][Full Text] [Related]
12. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
13. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
Zhang S; Tao X; Wang L; Chen H; Zhao L; Sun J; Bian S; Chen Z; Shao T; Yang Y; Li Y; Zhang F
Dig Dis Sci; 2022 Jul; 67(7):2981-2993. PubMed ID: 34392493
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
[TBL] [Abstract][Full Text] [Related]
16. Primary biliary cholangitis: pathogenic mechanisms.
Prieto J; Banales JM; Medina JF
Curr Opin Gastroenterol; 2021 Mar; 37(2):91-98. PubMed ID: 33332913
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8
Ma HD; Ma WT; Liu QZ; Zhao ZB; Liu MZ; Tsuneyama K; Gao JM; Ridgway WM; Ansari AA; Gershwin ME; Fei YY; Lian ZX
J Autoimmun; 2017 Mar; 78():19-28. PubMed ID: 28129932
[TBL] [Abstract][Full Text] [Related]
18. When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis.
Fickert P; Trauner M
J Hepatol; 2009 Mar; 50(3):633-5. PubMed ID: 19157624
[TBL] [Abstract][Full Text] [Related]
19. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
[TBL] [Abstract][Full Text] [Related]
20. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
